Skip to content
Tenfell
Awarded contract
Published 24 Oct 2025

RMH - CAR-T Treatment

The Royal Marsden NHS Foundation Trust · London

Key facts

Contract value
£380,000
Contract starts
01 Nov 2025
Contract ends
31 Oct 2026
Procedure
Direct award
Buyer type
Health

Description

CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials.

Categories (CPV)

Similar open tenders

About The Royal Marsden NHS Foundation Trust

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.